KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,779 | -17.8% | 14,900 | 0.0% | 0.03% | -22.9% |
| Q2 2023 | $157,940 | -14.6% | 14,900 | 0.0% | 0.04% | -50.0% |
| Q4 2022 | $184,909 | -4.7% | 14,900 | 0.0% | 0.07% | +45.8% |
| Q3 2022 | $194,000 | -29.7% | 14,900 | 0.0% | 0.05% | -20.0% |
| Q2 2022 | $276,000 | +15.0% | 14,900 | 0.0% | 0.06% | +27.7% |
| Q1 2022 | $240,000 | +11.6% | 14,900 | 0.0% | 0.05% | +27.0% |
| Q4 2021 | $215,000 | -24.8% | 14,900 | 0.0% | 0.04% | -28.8% |
| Q3 2021 | $286,000 | -4.0% | 14,900 | 0.0% | 0.05% | -10.3% |
| Q2 2021 | $298,000 | -29.2% | 14,900 | 0.0% | 0.06% | -34.8% |
| Q1 2021 | $421,000 | -16.6% | 14,900 | 0.0% | 0.09% | -22.6% |
| Q4 2020 | $505,000 | -1.0% | 14,900 | 0.0% | 0.12% | -17.3% |
| Q3 2020 | $510,000 | – | 14,900 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |